Skip to main content

Full Schedule

Full Schedule

  • Wednesday, October 16, 2024
  • 8:30 AM – 9:45 AM PT
    (18) Specialty Pharmaceuticals in Development
  • 10:15 AM – 11:15 AM PT
    (21) State Legislative and Regulatory Update
  • 10:15 AM – 11:30 AM PT
    (20) WIN-WIN: Negotiate Your Career with Confidence
  • 10:15 AM – 11:30 AM PT
    (22) Insights into Retinal Health: Bridging Payer Gaps for Timely and Equitable Care
  • 10:15 AM – 11:30 AM PT
    (23) Advancing Patient Care and Demonstrating Value in Specialty Pharmacy Using Technology and Data-Driven Quality Improvement Solutions
  • 10:30 AM – 11:45 AM PT
    (19) Maximizing Utilization and Continuity of Care: Advancing Adalimumab Biosimilar Adoption in Managed Care
  • 2:30 PM – 3:45 PM PT
    (24) Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
  • 2:30 PM – 3:45 PM PT
    (25) Current Patterns, Future Shifts, and Best Practices in U.S. Specialty Drug Coverage
  • 2:30 PM – 3:45 PM PT
    (26) Bridging the Gap: Development of Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers through the AMCP RWE Initiative
  • 2:30 PM – 3:45 PM PT
    (27) Pharmacoeconomics & Formulary Management Student Workshop
  • 4:00 PM – 5:15 PM PT
    (28) Navigating the Final Chapter: What’s Next for Your Managed Care Pharmacy Career Journey- Opportunity for Rewirement vs Retirement
  • 4:00 PM – 5:15 PM PT
    (29) CY 2025 Part D Redesign: A Medicare Odyssey
  • 4:00 PM – 5:15 PM PT
    (30) GLP-1 Agonists for Weight Management within the Commercially Insured Market: How Real-world Evidence Can Inform Benefit Design